CASEY NOLAN: Open Payments
NPI 1548931041 · WESTFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 23 payments from 6 companies in 2025. Trend: 2023 $150 · 2024 $197 · 2025 $683
Food & beverage: $683
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $156 |
| E.R. Squibb & Sons, L.L.C. | 4 | $118 |
| Alnylam Pharmaceuticals Inc. | 1 | $112 |
| Novartis Pharmaceuticals Corporation | 5 | $108 |
| Amgen Inc. | 6 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $89 |
Products named: ELIQUIS, VYNDAQEL, AMVUTTRA, LEQVIO, REPATHA, JARDIANCE, CAMZYOS.
Industry payments across MA — which companies pay providers there.
